-
-
-
-
-
-
-
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
-
-
-
-
-
-
-
OPTIMI Health adds 1mg and 2mg psilocybin doses for clinical research
-
-
-
-
-
-
-
Australia expands psychedelic therapy access with updated prescriber rules
-
-
-
-
-
-
-
Form F-1/A Optimi Health Corp.
-
-
-
-
-
-
16,229 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

